MedTrace Logo

Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn

NCT01037452 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2011-03-28

Study results available
· View outcomes & findings →

Summary

This study will investigate the safety and efficacy of an antacid/Lansoprazole combination product for the relief of heartburn after consuming a heartburn-inducing meal.

Conditions

  • Heartburn

Interventions

DRUG

Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg

Tablet

DRUG

Lansoprazole

Tablet

DRUG

Calcium carbonate/magnesium hydroxide

Tablet

DRUG

Placebo

Tablet

Sponsors & Collaborators

Principal Investigators

  • Novartis . · Novartis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01037452 on ClinicalTrials.gov